Preoperative Risk Stratification in Endometrial Cancer for Tailoring Lymph Node Staging
NCT07368205 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 350
Last updated 2026-05-22
Summary
The goal of this observational study is to evaluaty the accuracy of current risk stratification of patients with endometrial cancer and to redefine lymph node staging recommendations based on real-world clinical data. The main question it aims to answer is:
Is there any group of patients who doesn't need lymph node staging for proper indication of adjuvant treatment? Participants are note taking any intervention. They are treated according to current standard of care and followed 3-years after primary surgery.
Conditions
Interventions
- OTHER
-
No Intervention: Observational Cohort
No intervention
Sponsors & Collaborators
-
University Hospital Hradec Kralove
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-15
- Primary Completion
- 2028-02-29
- Completion
- 2031-02-28
Countries
- Czechia
Study Locations
More Related Trials
-
Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
NCT06385912 ·Status: COMPLETED
-
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
NCT04291612 ·Status: RECRUITING
-
Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms
NCT03624712 ·Status: RECRUITING
-
Patients Characteristics, Treatment Pattern & Outcomes of Patients With Advanced, Recurrent or Metastatic Endometrial Carcinoma
NCT05364905 ·Status: COMPLETED
-
Lymphadenectomy in Early Ovarian Cancer
NCT04710797 ·Status: RECRUITING ·Phase: NA
-
Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)
NCT02566811 ·Status: TERMINATED ·Phase: NA
-
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
NCT05548296 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer
NCT01244789 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Molecular Staging of Endometrial Cancer
NCT00340808 ·Status: COMPLETED
-
An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation
NCT07041606 ·Status: RECRUITING
-
Lymphadenectomy In Ovarian Neoplasms
NCT00712218 ·Status: COMPLETED ·Phase: NA
-
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NCT05236686 ·Status: RECRUITING ·Phase: NA
-
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France
NCT05204342 ·Status: COMPLETED
-
Sentinel Node Detection in Clinical Early Stage Ovarian Cancer
NCT01734746 ·Status: COMPLETED ·Phase: NA
-
Genomic Profiling of the Residual Disease of Advanced-stage Ovarian Cancer After Neoadjuvant Chemotherapy
NCT03491033 ·Status: COMPLETED
-
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
NCT01460979 ·Status: COMPLETED ·Phase: PHASE2
-
LYmphadenectomy After NeoAdjuvant Chemotherapy
NCT01724944 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Phase II Decentralized Pragmatic Trial of Adjuvant Doxorubicin - Trabectedin Chemotherapy in uLMS
NCT07076186 ·Status: RECRUITING ·Phase: PHASE2
-
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
NCT06553612 ·Status: RECRUITING ·Phase: NA
-
Optimize the Support of Patients in Pelvic Onco-gynecology Through Adapted Support Care in the Post-cancer Period. AFTERGYN Pilot Phase
NCT05731661 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
NCT04575935 ·Status: RECRUITING ·Phase: PHASE3
-
The Efficacy and Safety of FRD001 in Ultrasound Contrast Imaging for Malignant Ovarian Masses in Women
NCT06556342 ·Status: RECRUITING ·Phase: NA
-
Minimally Invasive Interval Debulking Surgery in Advanced Ovarian Cancer
NCT07031908 ·Status: NOT_YET_RECRUITING
-
Registry Platform Ovarian and Endometrial Cancer
NCT05129969 ·Status: RECRUITING